Home » Topics » BioWorld Science

BioWorld Science
RSS

Santen reports LTA4 hydrolase inhibitors

Nov. 8, 1996

Antiarthritic agents with good safety reported by Toyama

Nov. 8, 1996

IL-2 treatment dramatically effective in AIDS patients

Nov. 8, 1996

Cel-Sci reports interim results from AIDS vaccine trial

Nov. 8, 1996

Spanish phase II trial to evaluate Remune in combination with antiviral agents

Nov. 8, 1996

Procept and MRC clinical collaboration on topical microbicide

Nov. 8, 1996

MiKasome cleared for clinical trials in HIV-positive patients

Nov. 8, 1996

Novel nontoxic AIDS drug cleared for clinical trials

Nov. 8, 1996

Expanded access allowed for NTZ in AIDS patients

Nov. 8, 1996

Sankyo describes anti-HIV agents

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026